BioPorto A/S (THOXF)
OTCMKTS · Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024
BioPorto Employees
BioPorto had 48 employees as of December 31, 2024. The number of employees increased by 19 or 65.52% compared to the previous year.
Employees
48
Change (1Y)
19
Growth (1Y)
65.52%
Revenue / Employee
$117,549
Profits / Employee
-$276,716
Market Cap
90.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48 | 19 | 65.52% |
| Dec 31, 2023 | 29 | -3 | -9.38% |
| Dec 31, 2022 | 32 | 3 | 10.34% |
| Dec 31, 2021 | 29 | 1 | 3.57% |
| Dec 31, 2020 | 28 | -6 | -17.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
BioPorto News
- 4 weeks ago - BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented - GlobeNewsWire
- 2 months ago - BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. - GlobeNewsWire
- 2 months ago - BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. - Benzinga
- 3 months ago - BioPorto A/S to host an investor webcast on the results for the first half of 2025 - GlobeNewsWire
- 3 months ago - BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants. - GlobeNewsWire
- 4 months ago - BioPorto A/S Announces the Appointment of a New CEO as Part of its Succession Planning Strategy - GlobeNewsWire
- 6 months ago - BioPorto A/S to host first quarter 2025 earnings webcast for investors - GlobeNewsWire
- 6 months ago - BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million - GlobeNewsWire